Equities

Alpha IVF Group Bhd

ALPHA:KLS

Alpha IVF Group Bhd

Actions
Health CareHealth Care Providers
  • Price (MYR)0.33
  • Today's Change0.005 / 1.54%
  • Shares traded21.61m
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of May 17 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Alpha IVF Group Bhd is a Malaysia-based fertility science, research, and advancement company. The Company is involved in provision of assisted reproductive services through its specialist fertility care centers. The Company offers access to a comprehensive fertility services, technology, and labs across its fertility centers. Its assisted reproductive technologies (ART) refer to a range of medical technologies and treatments complemented with laboratory technologies and procedures to assist individuals or couples in overcoming the challenges of infertility. The Company’s Assisted reproductive services (ARS) include support services, such as fertility assessment, diagnostics and testing, monitoring, preconception care and counselling. The medical technologies and treatments of ART are primarily carried out by medical specialists in obstetrics and gynecology, who are also responsible for the prescription of fertility and other related drugs.

  • Revenue in MYR (TTM)--
  • Net income in MYR--
  • Incorporated2021
  • Employees96.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Abbisko Cayman Ltd12.38m-280.24m1.58bn258.00--1.23--127.49-0.7207-0.72070.03183.050.0083--1.4079,843.89-18.74---19.67--100.00---2,264.34------0.0177------12.92------
Alpha IVF Group Bhd-100.00bn-100.00bn1.60bn96.00--27.06----------0.0122------------------------2.80--0.2197--50.92--272.17------
Frontier Biotechnologies Inc82.40m-200.47m1.60bn395.00--1.92--19.47-0.8248-0.82480.3393.440.05751.403.00321,484.60-13.99-14.05-16.25-15.7830.102.35-243.30-450.082.86--0.2347--34.82126.637.79--28.13--
Innova Captab Ltd-5.63bn-5.63bn1.62bn--------------------------------------------------15.72--6.26------
SeQuent Scientific Ltd770.71m-20.18m1.63bn478.00--4.4290.652.11-1.45-1.4556.2726.320.89252.194.05---1.931.09-3.271.7644.5342.74-2.161.180.76020.13760.4062---3.605.6870.40--6.96--
SCI Pharmtech Inc175.41m42.93m1.63bn241.0035.532.2025.509.322.642.6412.8742.670.20671.645.01--5.066.905.728.2629.0938.1824.4819.852.5011.900.169742.3833.83-9.10-4.55-8.0044.67-16.35
Imugene Ltd0.00-279.97m1.65bn0.00--2.65-----0.0132-0.01320.000.02720.00-------40.29-26.64-43.53-28.00------------0.021-------0.1207------
Data as of May 17 2024. Currency figures normalised to Alpha IVF Group Bhd's reporting currency: Malaysian Ringgit MYR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.